You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.
This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.
This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.
NovoEight® Summary of Product Characteristics.
2. Elocta® Summary of Product Characteristics.
3. Nuwiq® Summary of Product Characteristics.
4. Afstyla® Summary of Product Characteristics.
5. ReFacto® Summary of Product Characteristics.
6. Advate® Summary of Product Characteristics.
7. Kogenate® Summary of Product Characteristics.
8 .Kovaltry® Summary of Product Characteristics.
9. Adynovi® Summary of Product Characteristics.
10. Lentz SR et al. Haemophilia 2018;24(6):e391-e394.
11. Tischer B et al. Patient Preference and Adherence 2018;12:431-441.